NMS-backed Flourish Research Recapitalizes Great Lakes Clinical Trials and Clinical Site Partners
January 12, 2022
NMS Capital portfolio company Flourish Research completed recapitalizations of Great Lakes Clinical Trials and Clinical Site Partners, expanding its multi-site clinical trial network across Illinois, Florida and Texas. The deals (terms undisclosed) add site capacity and management teams to Flourish Research as the platform pursues network consolidation, improved operational efficiencies and accelerated growth.
- Buyers
- Flourish Research, NMS Capital
- Targets
- Great Lakes Clinical Trials, Clinical Site Partners
- Platforms
- Flourish Research
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Recapitalization
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.